Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Thalidomide-O-amido-PEG3-C2-NH2 TFA (Cereblon Ligand-Linker Conjugates 3 (TFA)) is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG3-C2-NH2 TFA incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,500 | |||
10 mg | 在庫あり | ¥ 13,000 | |||
25 mg | 在庫あり | ¥ 18,500 | |||
50 mg | 在庫あり | ¥ 34,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,500 |
説明 | Thalidomide-O-amido-PEG3-C2-NH2 TFA (Cereblon Ligand-Linker Conjugates 3 (TFA)) is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-O-amido-PEG3-C2-NH2 TFA incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. |
別名 | E3 ligase Ligand-Linker Conjugates 14 TFA, Cereblon Ligand-Linker Conjugates 3 (TFA) |
分子量 | 620.54 |
分子式 | C25H31F3N4O11 |
CAS No. | 1957236-21-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (80.58 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Thalidomide-O-amido-PEG3-C2-NH2 TFA 1957236-21-3 Others PROTAC E3 Ligase Ligand-Linker Conjugate Ligand for E3 Ligase E3 Ligase Ligand-Linker Conjugates Thalidomide O amido PEG3 C2 NH2 TFA Cereblon Ligand-Linker Conjugates 3 Thalidomide-O-amido-PEG-3-C2-NH2 TFA E3 ligase Ligand-Linker Conjugates 14 E3 ligase Ligand-Linker Conjugates 14 TFA inhibit Inhibitor ThalidomideOamidoPEG3C2NH2 TFA Cereblon Ligand-Linker Conjugates 3 (TFA) inhibitor